Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Women whose partners actively support their weight loss efforts lose significantly more weight than those who attempt the process alone or without partner involvement
Healthy, active cells constantly replenish their supply of ATP
Goal: Maintain stability preventing progression while balancing cost and intervention burden
It can cause some side effects including stomach upset, nausea, vomiting, dry mouth, headache, and restlessness
First GLP-1 pill of its kind with flexible dosing Can be taken at any time of day No fasting or timing requirements Removes one of the biggest barriers vs injectable therapies Clinical impact (ATTain-1 trial): ~27 lbs average weight loss at highest dose ~12.4% body weight reduction Significant improvements in cardiometabolic markers (cholesterol, blood pressure, waist circumference) Weve seen explosive growth in GLP-1 injectables but: Many patients delay or avoid treatment due to injections Adherence can be a challenge Access and convenience remain barriers A simple oral option could expand the market significantly and reach patients earlier in their journey
Endocrinology 138 , 44454455 (1997)
US$ 23.34
US$ 20.70
US$ 27.79
